Syncrosome is a preclinical CRO dedicated to In vivo pharmacology since 12 years now and with a strong competency in Efficacy and Pharmacokinetics.
One of our department is dedicated to Central Nervous System and we propose a complete offer with:
- In vivo efficacy models in Parkinson and Stroke
- CNS-PK with Microdialysis and CSF sampling
Sandra Robelet, Head of CNS department, will attend the 8th Annual Biomarkers Congress, 19 & 20 Feb 2013, Manchester. It will ...
As you probably know Syncrosome offers Advanced services in CNS efficacy with model in Parkinson and Stroke diseases but also in CNS-PK thanks to microdialysis and CSF sampling.
Microdialysis is an in vivo technique allowing continuous sampling of molecules in brain extracellular space in the same animal.
Associated to a detection technique, Microdialysis allows the monitoring of Neurotransmitter such as Dopamine, Serotonin, Nor-Adrenaline but also drug delivery in a particular brain area....
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com